These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37695700)

  • 21. Molecular and translational advances in meningiomas.
    Suppiah S; Nassiri F; Bi WL; Dunn IF; Hanemann CO; Horbinski CM; Hashizume R; James CD; Mawrin C; Noushmehr H; Perry A; Sahm F; Sloan A; Von Deimling A; Wen PY; Aldape K; Zadeh G;
    Neuro Oncol; 2019 Jan; 21(Suppl 1):i4-i17. PubMed ID: 30649490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial.
    Graillon T; Sanson M; Campello C; Idbaih A; Peyre M; Peyrière H; Basset N; Autran D; Roche C; Kalamarides M; Roche PH; Fuentes S; Tabouret E; Barrie M; Cohen A; Honoré S; Boucekine M; Baumstarck K; Figarella-Branger D; Barlier A; Dufour H; Chinot OL
    Clin Cancer Res; 2020 Feb; 26(3):552-557. PubMed ID: 31969329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereotactic radiation treatment for recurrent nonbenign meningiomas.
    Mattozo CA; De Salles AA; Klement IA; Gorgulho A; McArthur D; Ford JM; Agazaryan N; Kelly DF; Selch MT
    J Neurosurg; 2007 May; 106(5):846-54. PubMed ID: 17542529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade.
    Schmidt M; Mock A; Jungk C; Sahm F; Ull AT; Warta R; Lamszus K; Gousias K; Ketter R; Roesch S; Rapp C; Schefzyk S; Urbschat S; Lahrmann B; Kessler AF; Löhr M; Senft C; Grabe N; Reuss D; Beckhove P; Westphal M; von Deimling A; Unterberg A; Simon M; Herold-Mende C
    Oncotarget; 2016 Mar; 7(12):14551-68. PubMed ID: 26894859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of adjuvant radiotherapy in atypical (WHO grade II) and anaplastic (WHO grade III) meningiomas: a systematic review.
    Delgado-López PD; Corrales-García EM
    Clin Transl Oncol; 2021 Feb; 23(2):205-221. PubMed ID: 32651886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The controversial role of Bevacizumab in the treatment of patients with intracranial meningioma: a comprehensive literature review.
    Scerrati A; Mongardi L; Visani J; Lofrese G; Cavallo MA; Fiorentino A; De Bonis P
    Expert Rev Anticancer Ther; 2020 Mar; 20(3):197-203. PubMed ID: 32116057
    [No Abstract]   [Full Text] [Related]  

  • 27. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival.
    Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ
    Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).
    Wen PY; Yung WK; Lamborn KR; Norden AD; Cloughesy TF; Abrey LE; Fine HA; Chang SM; Robins HI; Fink K; Deangelis LM; Mehta M; Di Tomaso E; Drappatz J; Kesari S; Ligon KL; Aldape K; Jain RK; Stiles CD; Egorin MJ; Prados MD
    Neuro Oncol; 2009 Dec; 11(6):853-60. PubMed ID: 19293394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapy and targeted therapies for meningiomas: what is the evidence?
    Graillon T; Tabouret E; Chinot O
    Curr Opin Neurol; 2021 Dec; 34(6):857-867. PubMed ID: 34629433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydroxyurea with or without imatinib in the treatment of recurrent or progressive meningiomas: a randomized phase II trial by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
    Mazza E; Brandes A; Zanon S; Eoli M; Lombardi G; Faedi M; Franceschi E; Reni M
    Cancer Chemother Pharmacol; 2016 Jan; 77(1):115-20. PubMed ID: 26659583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
    Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
    Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features.
    Yang SY; Park CK; Park SH; Kim DG; Chung YS; Jung HW
    J Neurol Neurosurg Psychiatry; 2008 May; 79(5):574-80. PubMed ID: 17766430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of radiotherapy in the management of high-grade meningiomas.
    Hwang KL; Hwang WL; Bussière MR; Shih HA
    Chin Clin Oncol; 2017 Jul; 6(Suppl 1):S5. PubMed ID: 28758409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway.
    Schrell UM; Rittig MG; Anders M; Kiesewetter F; Marschalek R; Koch UH; Fahlbusch R
    J Neurosurg; 1997 May; 86(5):845-52. PubMed ID: 9126901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current immunotherapy techniques in meningioma.
    White AJ; Harary M; Casaos J; Everson RG
    Expert Rev Anticancer Ther; 2024 Oct; 24(10):931-941. PubMed ID: 39233324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas.
    Ferraro DJ; Funk RK; Blackett JW; Ju MR; DeWees TA; Chicoine MR; Dowling JL; Rich KM; Drzymala RE; Zoberi I; Simpson JR; Jaboin JJ
    Radiat Oncol; 2014 Jan; 9():38. PubMed ID: 24467972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concomitant Temozolomide plus radiotherapy for high-grade and recurrent meningioma: a retrospective chart review.
    Belanger K; Ung TH; Damek D; Lillehei KO; Ormond DR
    BMC Cancer; 2022 Apr; 22(1):367. PubMed ID: 35392834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Necrosis and Brain Invasion Predict Radio-Resistance and Tumor Recurrence in Atypical Meningioma: A Retrospective Cohort Study.
    Garcia-Segura ME; Erickson AW; Jairath R; Munoz DG; Das S
    Neurosurgery; 2020 Dec; 88(1):E42-E48. PubMed ID: 32818240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of Treatment Response and Survival Outcomes in Meningioma Recurrence with Atypical or Anaplastic Histology.
    Chohan MO; Ryan CT; Singh R; Lanning RM; Reiner AS; Rosenblum MK; Tabar V; Gutin PH
    Neurosurgery; 2018 Jun; 82(6):824-832. PubMed ID: 28645194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical Resection and Interstitial Iodine-125 Brachytherapy for High-Grade Meningiomas: A 25-Year Series.
    Magill ST; Lau D; Raleigh DR; Sneed PK; Fogh SE; McDermott MW
    Neurosurgery; 2017 Mar; 80(3):409-416. PubMed ID: 27258768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.